Frontlight ResearchEarly access
Active, not recruitingNo phase
Repeated Low-Level Red-Light Therapy for Shortening Axial Length
Key facts
- Who runs it
- Shanghai Eye Disease Prevention and Treatment Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 30 people, planned
- Started
- 19 Nov 2022
- Ended
- 23 Mar 2026
- Type of study
- Interventional
- Treatments tested
- RLRL
- Record updated
- 30 March 2025
Who can take part
- Age
- 6 years to 16 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Provision of consent
- Age: ≥ 6 and ≤ 16 years at enrolment
- High myopia: cycloplegic sphere ≤ -6.00 diopters (D) in both eyes
- Willing and able to participate in all required activities of the study
- The children currently on myopia control treatment can be recruited if myopia control treatments (including but not limited to atropine, orthokeratology, rigid gas-permeable lenses, defocus spectacles, etc.) are discontinued for at least 2 weeks
- Normal fundus, tessellated fundus or with peripapillary diffuse chorioretinal atrophy
Who cannot take part
- Previous any intraocular surgery affecting refractive status
- Secondary myopia, such as a history of retinopathy of prematurity or neonatal problems, or syndromic myopia with a known genetic disease or connective tissue disorders, such as Stickler or Marfan syndrome
- Pathologic myopia with signs of macula-involving diffuse chorioretinal atrophy, patchy chorioretinal atrophy, macular atrophy, lacquer cracks, myopic choroidal neovascularization or Fuchs' spots
- Strabismus and binocular vision abnormalities in either eye
- Other reasons, including but not limited to ocular or other systemic abnormalities, that the physician may consider inappropriate for enrolment
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of this clinical trial is to confirm the incidence and magnitude of axial length shortening after RLRL therapy in Chinese high myopia children and teenagers.
The group in the trial
- RLRL therapyTreatment being tested
In addition to SVS, participants will be treated with RLRL twice a school day.
Treatment: RLRL
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Repeated Low-Level Red-Light Therapy for Shortening Axial Length in Chinese High Myopia Children and Teenagers: a Prospective Single-Arm Study
- Record updated
- 30 March 2025